Oncology

Even low-to-moderate drinking can increase cancer risk.

Liquid biopsy analyzes the urine of patients who underwent digital rectal examinations.

Inferiority ruled for biosimilar of trastuzumab in the treatment of HER2-positive early breast cancer.

Inferiority ruled for biosimilar of trastuzumab in the treatment of HER2-positive early breast cancer.

New approach seeks to overcome chemotherapy resistance in cancer cells.

Colon cancer screenings are largely underutilized.

Precision medicine allows targeting of protein in acute myeloid leukemia.

CBX8 protein may lead to new treatments for breast cancer.

Protein that helps cancer cells survive during metastasis may lead to novel treatments.

ABT-414 receives designation for the treatment of diffuse intrinsic pontine glioma (DIPG).

Recent advances and updates in oncology and cancer drug development.

Top news of the day from across the health care landscape.

An award of $55 million will help launch different infrastructure needed to improve precision medicine.

Surgery combined with chemotherapy and radiation may be a good option for pancreatic cancer patients whose tumors involved blood vessels.

Chimeric antigen receptor T cell therapy targets advanced forms of leukemia and lymphoma.

Some tumors can remain undetected from current cancer treatments.

A new study’s findings contradict previous assumptions about IVF and breast cancer risk.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Gross total resection is difficult to achieve due to complexities involved with brain cancer.

Is the cost of specialty drugs worth the price in small patient populations?

Phase 2 clinical trial of brentuximab vedotin (Adcetris) monotherapy in relapsed or refractory classical Hodgkin lymphoma treatment shows improved survival.

Obinutuzumab not found to improve progression-free survival in untreated diffuse large B-cell lymphoma.

Notch signaling pathway found to drive prostate cancer metastasis.

Top news of the day from across the health care landscape.

Self-reported prevalence of prostate cancer found lower in men who take aspirin.

The cancer mortality rate declined 1.55 % in 2011.

Benign meningioma tumors may be less likely in patients with high blood sugar.

Patients who underwent gross total resection had a significantly increased 1-year survival rate.

Even in early clinical trials for cancer drugs, the use of precision medicine showed longer progression-free survival.